ArticleBMC cancer2025
Exploring irisin levels in patients with endometrial atypical hyperplasia and carcinoma: a comparative analysis.
Article in BMC cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEndometrial atypical hyperplasia (EAH) is recognized as the precursor to type I endometrial cancer. Endometrial cancer (EC), strongly associated with disorders in glucose metabolism such as obesity and insulin resistance, is believed to be influenced by hormones secreted from adipose tissue known as adipokines.
methodsIn a cross-sectional case-control study, 88 patients diagnosed with either EAH or EC were enrolled. Their irisin levels in serum were compared to those of a control group.
resultsIrisin levels were significantly higher in patients with both EAH and EC compared to the control group (p = 0.022). In multivariable analysis, the association between irisin and EAH remained statistically significant and independent after adjustment for covariates (p = 0.018), whereas the association with EC was weakened and did not remain statistically significant (p = 0.071).
conclusionWe demonstrated that Irisin levels in patients with EAH or EC differ from those in a control group, suggesting that irisin levels are correlated with the risks of EH and EC. Larger studies are required to clarify the potential use of irisin in the diagnosis of EC.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.